| Dr Michael Patrick O'reilly, MD | |
|
2 Pond Park Rd Ste 102, Hingham, MA 02043-4354 | |
| (781) 337-5555 | |
| (781) 335-6047 |
| Full Name | Dr Michael Patrick O'reilly |
|---|---|
| Gender | Male |
| Speciality | Orthopedic Surgery |
| Experience | 22 Years |
| Location | 2 Pond Park Rd Ste 102, Hingham, Massachusetts |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1730355447 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207X00000X | Orthopaedic Surgery | 257737 (Massachusetts) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Virginia Healthcare Services | Annandale, VA | Home health agency |
| Virginia Hospital Center | Arlington, VA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Kaiser Foundation Health Plan Of The Mid-atlantic States,inc | 3779495858 | 1673 |
| Kaiser Foundation Health Plan Of The Mid-atlantic States,inc | 3779495858 | 1673 |
News Archive
Johnson & Johnson provided additional information today on its amended agreement with Merck regarding distribution rights for REMICADE (infliximab) and SIMPONI (golimumab) in markets outside the United States. The amended agreement announced today in a separate news release from both companies concludes a pending arbitration, which had been filed by Johnson & Johnson in May 2009.
As Catholic health care systems across the country expand, the University of California's flagship San Francisco hospital has become the latest arena for an emotional debate: Should the famously progressive medical center increase its treatment space by joining forces with a Catholic-run system that restricts care according to religious doctrine?
The New York Times reports that partisan gridlock will likely prevent Congress from making even small adjustments. Meanwhile, a CNN poll finds that a majority of Americans continue to oppose the measure, which adds to the Obama administration's challenge of selling it to the public.
An exciting new study by researchers at the Universities of Oxford and Edinburgh and published on the preprint server medRxiv* in July 2020 reports that early and stringent government measures in the form of non-pharmaceutical interventions (NPIs) against the spread of COVID-19 results in a significant reduction in the mortality due to this disease. The finding could help shape public health policies in the absence of effective vaccines or therapeutic drugs.
Salix Pharmaceuticals, Ltd. and Alfa Wassermann S.p.A. today announced that they have entered into an exclusive agreement by which Salix has licensed rights in the United States and Canada to an extended intestinal release (EIR) formulation of rifaximin for gastrointestinal and respiratory indications, including Crohn's disease.
› Verified 6 days ago
| Entity Name | Kaiser Foundation Health Plan Of The Mid-atlantic States,inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1952461816 PECOS PAC ID: 3779495858 Enrollment ID: O20040105000308 |
News Archive
Johnson & Johnson provided additional information today on its amended agreement with Merck regarding distribution rights for REMICADE (infliximab) and SIMPONI (golimumab) in markets outside the United States. The amended agreement announced today in a separate news release from both companies concludes a pending arbitration, which had been filed by Johnson & Johnson in May 2009.
As Catholic health care systems across the country expand, the University of California's flagship San Francisco hospital has become the latest arena for an emotional debate: Should the famously progressive medical center increase its treatment space by joining forces with a Catholic-run system that restricts care according to religious doctrine?
The New York Times reports that partisan gridlock will likely prevent Congress from making even small adjustments. Meanwhile, a CNN poll finds that a majority of Americans continue to oppose the measure, which adds to the Obama administration's challenge of selling it to the public.
An exciting new study by researchers at the Universities of Oxford and Edinburgh and published on the preprint server medRxiv* in July 2020 reports that early and stringent government measures in the form of non-pharmaceutical interventions (NPIs) against the spread of COVID-19 results in a significant reduction in the mortality due to this disease. The finding could help shape public health policies in the absence of effective vaccines or therapeutic drugs.
Salix Pharmaceuticals, Ltd. and Alfa Wassermann S.p.A. today announced that they have entered into an exclusive agreement by which Salix has licensed rights in the United States and Canada to an extended intestinal release (EIR) formulation of rifaximin for gastrointestinal and respiratory indications, including Crohn's disease.
› Verified 6 days ago
| Entity Name | Kaiser Foundation Health Plan Of The Mid-atlantic States,inc |
|---|---|
| Entity Type | Part B Supplier - Ambulatory Surgical Center |
| Entity Identifiers | NPI Number: 1073678637 PECOS PAC ID: 3779495858 Enrollment ID: O20100729000796 |
News Archive
Johnson & Johnson provided additional information today on its amended agreement with Merck regarding distribution rights for REMICADE (infliximab) and SIMPONI (golimumab) in markets outside the United States. The amended agreement announced today in a separate news release from both companies concludes a pending arbitration, which had been filed by Johnson & Johnson in May 2009.
As Catholic health care systems across the country expand, the University of California's flagship San Francisco hospital has become the latest arena for an emotional debate: Should the famously progressive medical center increase its treatment space by joining forces with a Catholic-run system that restricts care according to religious doctrine?
The New York Times reports that partisan gridlock will likely prevent Congress from making even small adjustments. Meanwhile, a CNN poll finds that a majority of Americans continue to oppose the measure, which adds to the Obama administration's challenge of selling it to the public.
An exciting new study by researchers at the Universities of Oxford and Edinburgh and published on the preprint server medRxiv* in July 2020 reports that early and stringent government measures in the form of non-pharmaceutical interventions (NPIs) against the spread of COVID-19 results in a significant reduction in the mortality due to this disease. The finding could help shape public health policies in the absence of effective vaccines or therapeutic drugs.
Salix Pharmaceuticals, Ltd. and Alfa Wassermann S.p.A. today announced that they have entered into an exclusive agreement by which Salix has licensed rights in the United States and Canada to an extended intestinal release (EIR) formulation of rifaximin for gastrointestinal and respiratory indications, including Crohn's disease.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Michael Patrick O'reilly, MD 2 Pond Park Rd Ste 102, Hingham, MA 02043-4354 Ph: (781) 337-5555 | Dr Michael Patrick O'reilly, MD 2 Pond Park Rd Ste 102, Hingham, MA 02043-4354 Ph: (781) 337-5555 |
News Archive
Johnson & Johnson provided additional information today on its amended agreement with Merck regarding distribution rights for REMICADE (infliximab) and SIMPONI (golimumab) in markets outside the United States. The amended agreement announced today in a separate news release from both companies concludes a pending arbitration, which had been filed by Johnson & Johnson in May 2009.
As Catholic health care systems across the country expand, the University of California's flagship San Francisco hospital has become the latest arena for an emotional debate: Should the famously progressive medical center increase its treatment space by joining forces with a Catholic-run system that restricts care according to religious doctrine?
The New York Times reports that partisan gridlock will likely prevent Congress from making even small adjustments. Meanwhile, a CNN poll finds that a majority of Americans continue to oppose the measure, which adds to the Obama administration's challenge of selling it to the public.
An exciting new study by researchers at the Universities of Oxford and Edinburgh and published on the preprint server medRxiv* in July 2020 reports that early and stringent government measures in the form of non-pharmaceutical interventions (NPIs) against the spread of COVID-19 results in a significant reduction in the mortality due to this disease. The finding could help shape public health policies in the absence of effective vaccines or therapeutic drugs.
Salix Pharmaceuticals, Ltd. and Alfa Wassermann S.p.A. today announced that they have entered into an exclusive agreement by which Salix has licensed rights in the United States and Canada to an extended intestinal release (EIR) formulation of rifaximin for gastrointestinal and respiratory indications, including Crohn's disease.
› Verified 6 days ago
Dr. John J. Kadzielski, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2 Pond Park Rd, Suite 102, Hingham, MA 02043 Phone: 781-337-5555 | |
Owen Robert Mcconville, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2 Pond Park Rd., Ste. 102, Hingham, MA 02043 Phone: 781-337-5555 Fax: 781-331-0300 | |
Dr. Michael W. Geary, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2 Pond Park Rd., Ste. 102, Hingham, MA 02043 Phone: 781-337-5555 Fax: 781-331-0300 | |
Katherine Mary Merra, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2 Pond Park Rd., Ste. 102, Hingham, MA 02043 Phone: 781-337-5555 Fax: 781-331-0300 | |
James E Devin, MD Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 2 Pond Park Rd., Ste. 102, Hingham, MA 02043 Phone: 781-337-5555 Fax: 781-331-0300 | |
Arthur James Bowman Jr., MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2 Pond Park Rd., Ste. 102, Hingham, MA 02043 Phone: 781-337-5555 Fax: 781-331-0300 | |
Christopher W Rynne, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2 Pond Park Rd, Suite 102, Hingham, MA 02043 Phone: 781-337-5555 Fax: 781-335-6047 |